Circulating microRNAs as potential biomarkers in pancreatic cancer—advances and challenges

AA Seyhan - International journal of molecular sciences, 2023 - mdpi.com
There is an urgent unmet need for robust and reliable biomarkers for early diagnosis,
prognosis, and prediction of response to specific treatments of many aggressive and deadly …

An overview of circulating biomarkers in neuroendocrine neoplasms: a clinical guide

M Bevere, F Masetto, ME Carazzolo, A Bettega… - Diagnostics, 2023 - mdpi.com
Neuroendocrine neoplasms (NENs) are a heterogeneous group of diseases that are
characterized by different behavior and clinical manifestations. The diagnosis and …

Exploring the theranostic potentials of miRNA and epigenetic networks in autoimmune diseases: A comprehensive review

S Nag, O Mitra, G Tripathi, S Samanta… - Immunity …, 2023 - Wiley Online Library
Background Autoimmune diseases (AD) are severe pathophysiological ailments that are
stimulated by an exaggerated immunogenic response towards self‐antigens, which can …

Epigenetic regulation in gastroenteropancreatic neuroendocrine tumors

JS Crabtree - Frontiers in Oncology, 2022 - frontiersin.org
Gastroenteropancreatic neuroendocrine neoplasms are a rare, diverse group of
neuroendocrine tumors that form in the pancreatic and gastrointestinal tract, and often …

Recent developments in the diagnosis of pancreatic neuroendocrine neoplasms

A Battistella, M Tacelli, P Mapelli… - Expert Review of …, 2024 - Taylor & Francis
ABSTRACT Introduction Pancreatic Neuroendocrine Neoplasms (PanNENs) are
characterized by a highly heterogeneous clinical and biological behavior, making their …

Biochemical Markers for Neuroendocrine Tumors: Traditional Circulating Markers and Recent Development—A Comprehensive Review

M Franchina, F Cavalcoli, O Falco, M La Milia, A Elvevi… - Diagnostics, 2024 - mdpi.com
Biochemical Markers for Neuroendocrine Tumors: Traditional Circulating Markers and Recent
Development—A Comprehensive Review Page 1 Diagnostics 2024, 14, 1289. https://doi.org/10.3390/diagnostics14121289 …

Evaluation of a blood miRNA/mRNA signature to follow-up Lu-PRRT therapy for G1/G2 intestinal neuroendocrine tumors

V Jacques, L Dierickx, JS Texier, S Brillouet… - Frontiers in …, 2024 - frontiersin.org
Background 177Lu-oxodotreotide peptide receptor therapy (LuPRRT) is an efficient
treatment for midgut neuroendocrine tumors (NETs) of variable radiological response …

Improvements and future perspective in diagnostic tools for neuroendocrine neoplasms

S Massironi, M Franchina, D Ippolito… - Expert Review of …, 2024 - Taylor & Francis
ABSTRACT Introduction Neuroendocrine neoplasms (NENs) represent a complex group of
tumors arising from neuroendocrine cells, characterized by heterogeneous behavior and …

Towards Personalized Treatment and Molecular Research on Gastrointestinal Tumors

A Passardi, E Scarpi, P Ulivi - International Journal of Molecular Sciences, 2023 - mdpi.com
Gastrointestinal cancers (GC) account for 26% of all cancer incidences and 35% of all
cancer-related deaths [1]. Despite the decrease in the incidence of some GC subtypes, this …

[PDF][PDF] 肿瘤分子病理学中的调节性RNA

潘秀懿, 苏征征, 钟金晶, 余婷, 卫昱燕… - 中国科学: 生命 …, 2022 - researchgate.net
摘要肿瘤发生与发展的主要分子基础是基因表达调控紊乱. 调节性RNA 在基因表达调控各个
环节和各种细胞生物学过程中发挥重要作用. microRNA, circRNA, lncRNA, piRNA, snoRNA …